within Pharmacolibrary.Drugs.ATC.A;

model A07XA01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,   // mg â†’ kg
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A07XA01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Albumin tannate is a compound formed from albumin and tannic acid, used primarily as an antidiarrheal agent to reduce stool frequency and treat symptoms of acute or chronic diarrhea. It acts by forming a protective layer over the intestinal mucosa. It is approved and available in some countries, often in combination with other agents.</p><h4>Pharmacokinetics</h4><p>No published studies providing pharmacokinetic parameters (such as absorption, distribution, metabolism, or excretion) for albumin tannate in humans could be identified in biomedical literature as of 2024.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A07XA01;
